Onconetix, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2024 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Onconetix, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2024 to Q3 2024.
  • Onconetix, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$56.4K.
  • Onconetix, Inc. annual Income Tax Expense (Benefit) for 2023 was -$12.6K.
  • Onconetix, Inc. annual Income Tax Expense (Benefit) for 2022 was $3.16T.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$56.4K Jul 1, 2024 Sep 30, 2024 10-Q 2024-12-10
Q2 2024 $50.8K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-29
Q1 2024 -$122K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.